$50,000 of OMNICELL lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues pertaining to the Medicare programs treatment of automated drug compounding technology (Safer Compounding in Hospitals Act (HR 8749)"
You can find more data on corporate lobbying on Quiver Quantitative.
OMCL Insider Trading Activity
OMCL insiders have traded $OMCL stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $OMCL stock by insiders over the last 6 months:
- MARK W PARRISH sold 12,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OMCL Hedge Fund Activity
We have seen 111 institutional investors add shares of OMCL stock to their portfolio, and 132 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CADIAN CAPITAL MANAGEMENT, LP removed 1,674,367 shares (-67.7%) from their portfolio in Q3 2024
- VICTORY CAPITAL MANAGEMENT INC added 1,138,921 shares (+11982.3%) to their portfolio in Q3 2024
- PACER ADVISORS, INC. removed 823,914 shares (-39.8%) from their portfolio in Q3 2024
- LAZARD ASSET MANAGEMENT LLC added 773,966 shares (+593.9%) to their portfolio in Q3 2024
- GENEVA CAPITAL MANAGEMENT LLC removed 621,679 shares (-100.0%) from their portfolio in Q3 2024
- JANE STREET GROUP, LLC removed 442,699 shares (-89.8%) from their portfolio in Q3 2024
- TRIBUTARY CAPITAL MANAGEMENT, LLC removed 315,127 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
